Related Experiment Video

Updated: May 16, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Advanced materials for co-delivery of drugs and genes in cancer therapy

Majad Khan1, Zhan Yuin Ong, Nikken Wiradharma

  • 1Institute of Bioengineering and Nanotechnology, 31 Biopolis Way, Singapore 138669.

Advanced Healthcare Materials
|November 28, 2012
PubMed

Insights

Cancer multidrug-resistance is a major challenge. This report explores nanocarriers for simultaneous drug and gene delivery to overcome resistance and improve cancer therapy effectiveness.

Area of Science:

  • Oncology and Nanomedicine

Background:

  • Cancer is a leading global cause of mortality, necessitating novel therapeutic strategies.
  • Multidrug-resistance in cancer chemotherapy, often due to genetic factors, significantly limits treatment efficacy.
  • Advances in molecular biology and engineering enable the development of targeted cancer therapies.

Purpose of the Study:

  • To summarize recent progress in nanocarrier development for combined drug and gene delivery in cancer therapy.
  • To highlight the potential of co-delivery systems in overcoming multidrug-resistance.
  • To discuss challenges and future directions in designing nanocarriers for dual therapeutic agent delivery.

Main Methods:

  • Review of polymers, peptides, liposomes, and inorganic materials as nanocarrier platforms.
  • Focus on nanocarriers designed for the co-delivery of small molecule drugs and genetic material (genes or proteins).
  • Analysis of strategies to enhance drug and gene delivery to cancer cells.

Main Results:

  • Nanocarriers offer a promising approach for the simultaneous delivery of drugs and genes.
  • Co-delivery systems can potentially sensitize cancer cells to chemotherapeutics, overcoming multidrug-resistance.
  • Various nanomaterials demonstrate potential for effective co-delivery applications.

Conclusions:

  • Nanocarriers are crucial for advancing cancer therapy by enabling co-delivery of drugs and genes.
  • Overcoming multidrug-resistance through gene correction and chemosensitization is a key therapeutic goal.
  • Continued research into nanocarrier design is essential for future cancer treatment innovations.

More Related Videos

Manufacture and Drug Delivery Applications of Silk Nanoparticles09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

Preparation and In Vitro Characterization of Magnetized miR-modified Endothelial Cells09:58

Preparation and In Vitro Characterization of Magnetized miR-modified Endothelial Cells

Published on: May 2, 2017

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...